Thomas Brannagan
Peripheral Nerve Disorders Fellowship Program Director · New York Presbyterian Hospital
Credentials: · · · · ·
History
PresentPeripheral Nerve Disorders Fellowship · New York Presbyterian Hospital
- Present
Peripheral Neuropathy Center · New York Presbyterian Hospital
- Present
Columbia Neuropathy Research Center · New York Presbyterian Hospital
- 1998–1999
Neuromuscular Medicine
- 1991–1994
Neurological Institute of Columbia Presbyterian Medical Center
- 1982–1986
Research
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
New England Journal of Medicine · 2018 · 2,387 citations
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
New England Journal of Medicine · 2018 · 1,143 citations
Journal of the American College of Cardiology · 2023 · 520 citations
- NL
27 papers
- HS
24 papers
21 papers · 13 as a resident
14 papers
13 papers
- PG
12 papers
- AH
11 papers
- MP
9 papers
Clinical trials
- 2011–2014
Principal investigator · Terminated · Phase 3
Columbia University
- 2004–2006
Principal investigator · Completed · Phase 4
Weill Medical College of Cornell University